| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5b5454abd09f216530c44daae0e81afa
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6414cf0912e2737a41f574e3435772e3 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-71
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-495
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-17
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K19-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-71
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-395
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-17
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-28 |
| filingDate |
2020-11-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_be4c7514afcb4cb04ac1c2bfe330947d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_035525c89ae6a71b943747441c4cfb6e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c1352df1e94b23f561962a75116e52fb |
| publicationDate |
2021-08-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
TW-202128763-A |
| titleOfInvention |
Fusion protein containing tgf-β receptor and the pharmaceutical use thereof |
| abstract |
The present disclosure relates to fusion proteins containing TGF-β receptor and the pharmaceutical use thereof. Specifically, the present disclosure relates to a bifunctional fusion protein containing the PD-1 antibody as targeting portion and the extracellular region of TGF-βRII, and a pharmaceutical composition containing the fusion protein of TGF-β receptor, and its use as anti-cancer drugs. |
| priorityDate |
2019-11-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |